Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2016 (2016), Article ID 6148357, 8 pages
http://dx.doi.org/10.1155/2016/6148357
Review Article

In Vivo Radionuclide Generators for Diagnostics and Therapy

1Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
2Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen, Denmark
3Cluster for Molecular Imaging, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark
4Center for Nuclear Technologies, Technical University of Denmark, Roskilde, Denmark
5Department of Chemistry, Michigan State University, East Lansing, MI, USA
6Facility for Rare Isotope Beams, Michigan State University, East Lansing, MI, USA

Received 20 August 2016; Accepted 8 November 2016

Academic Editor: Spyros P. Perlepes

Copyright © 2016 Patricia E. Edem et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Brucer, “William Duane and the radium cow: an American contribution to an emerging atomic age,” Medical Physics, vol. 20, no. 6, p. 1601, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Stöcklin, S. M. Qaim, and F. Rösch, “The impact of radioactivity on medicine,” Radiochimica Acta, vol. 70-71, no. 249, pp. 249–272, 1995. View at Google Scholar
  3. L. Mausner, R. Straub, and S. Srivastava, “The in vivo generator for radioimmunotherapy,” Journal of Labelled Compounds and Radiopharmaceuticals, vol. 26, no. 1-12, pp. 498–500, 1989. View at Publisher · View at Google Scholar
  4. T. Jones and C. M. E. Matthews, “Tissue perfusion measured using the ratio of 81Rb to 81mkr incorporated in the tissue,” Nature, vol. 230, no. 5289, pp. 119–120, 1971. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Rösch and F. F. Knapp, “Radionuclide generators,” in Handbook of Nuclear Chemistry: Radiochemistry and Radiopharmaceutical Chemistry in Life Sciences, F. R. Attila Vértes, S. Nagy, Z. Klencsár, and R. G. Lovas, Eds., vol. 4, pp. 1935–1976, 2nd edition, 2003. View at Google Scholar
  6. L. Szilard and T. A. Chalmers, “Chemical separation of the radioactive element from its bombarded isotope in the Fermi effect,” Nature, vol. 134, no. 3386, p. 462, 1934. View at Google Scholar · View at Scopus
  7. K. P. Zhernosekov, Radiochemical aspects of production and processing of radiometals for preparation of metalloradiopharmaceuticals [Ph.D. thesis], Johannes Gutenberg-Universität Mainz, Mainz, Germany, 2006.
  8. K. P. Zhernosekov, D. V. Filosofov, S. M. Qaim, and F. Rosch, “A 140Nd/140Pr radionuclide generator based on physico-chemical transitions in 140Pr complexes after electron capture decay of 140Nd-DOTA,” Radiochimica Acta, vol. 95, no. 6, pp. 319–327, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. van Rooyen, Z. Szucs, and J. Rijn Zeevaart, “A possible in vivo generator 103Pd103mRh—Recoil considerations,” Applied Radiation and Isotopes, vol. 66, no. 10, pp. 1346–1349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. R. Zeevaart, Z. Szucs, S. Takacs, J. Van Rooyen, and D. Jansen, “Recoil and conversion electron implications to be taken into account in the design of therapeutic radiopharmaceuticals utilising in vivo generators,” Journal of Labelled Compounds and Radiopharmaceuticals, vol. 55, no. 3, pp. 115–119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. Szucs, J. van Rooyen, and J. R. Zeevaart, “Recoil effect on β-decaying in vivo generators, interpreted for 103Pd/103mRh,” Applied Radiation and Isotopes, vol. 67, no. 7-8, pp. 1401–1404, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. R. Zeevaart, Z. Szücs, S. Takács, N. V. Jarvi, and D. Jansen, “Recoil and conversion electron considerations of the 166Dy/ 166Ho in vivo generator,” Radiochimica Acta, vol. 100, no. 2, pp. 109–113, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Huclier-Markai, R. Kerdjoudj, C. Alliot et al., “Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with 44m/44Sc and experimental evidence of the feasibility of an in vivo PET generator,” Nuclear Medicine and Biology, vol. 41, pp. e36–e43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. V. Rao, G. J. Hallee, M. E. Ottlinger, and S. R. Sastry, “Radiations emitted in the decay of 165Er: a promising medical radionuclide,” Medical Physics, vol. 4, no. 3, p. 177, 1977. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Nath, M. J. Prushan, and J. G. Gilbert, “Can super-excited molecules survive fragmentation?” Journal of Radioanalytical and Nuclear Chemistry, vol. 247, no. 3, pp. 589–591, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. “National Nuclear Data Center: Decay Radiation Search,” http://www.nndc.bnl.gov/nudat2/indx_dec.jsp.
  17. G. J. Beyer, R. Bergmann, K. Schomäcker et al., “Comparison of the Biodistribution of 225Ac and Radio-Lanthanides as Citrate Complexes,” Isotopenpraxis Isotopes in Environmental and Health Studies, vol. 26, no. 3, pp. 111–114, 1990. View at Publisher · View at Google Scholar
  18. S. A. Graves, R. Hernandez, J. Fonslet et al., “Novel preparation methods of 52Mn for immunoPET imaging,” Bioconjugate Chemistry, vol. 26, no. 10, pp. 2118–2124, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. J. T. Jørgensen, M. Persson, J. Madsen, and A. Kjær, “High tumor uptake of 64Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers,” Nuclear Medicine and Biology, vol. 40, no. 3, pp. 345–350, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. G. W. Severin, J. T. Jørgensen, S. Wiehr et al., “The impact of weakly bound 89Zr on preclinical studies: non-specific accumulation in solid tumors and aspergillus infection,” Nuclear Medicine and Biology, vol. 42, no. 4, pp. 360–368, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Jones and J. C. Clark, “A cyclotron produced 81Rb-81mKr generator and its uses in gamma-camera studies,” British Journal of Radiology, vol. 42, no. 495, p. 237, 1969. View at Google Scholar · View at Scopus
  22. E. Kaplan, L. W. Mayron, W. E. Barnes, L. G. Colombetti, A. M. Friedman, and J. E. Gindler, “Continuous radionuclide generation. II. Scintigraphic definition of capillary exchange by rapid decay of 81mKr and its applications,” Journal of Nuclear Medicine, vol. 15, no. 10, pp. 874–879, 1974. View at Google Scholar · View at Scopus
  23. H.-P. Stoll, W. Bay, W. Vogel et al., “Myocardial perfusion measured by dual-isotope acquisition of 81rubidium/81mkrypton: an experimental verification of the method,” Basic Research In Cardiology, vol. 89, no. 4, pp. 354–365, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. G. van Herk and D. de Zeeuw, “Unilateral kidney blood flow measurement using the 81Rb/81mKr ratio,” Contributions to Nephrology, vol. 11, pp. 67–72, 1978. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Jones, J. E. Pettit, C. G. Rhodes, and S. L. Waters, “The measurement of spleen perfusion in man: a non-invasive method using the ratio between rubidium-81 and its decay product krypton-81m,” European Journal of Nuclear Medicine, vol. 2, no. 4, pp. 219–224, 1977. View at Publisher · View at Google Scholar · View at Scopus
  26. A. I. Jensen, G. W. Severin, H. B. Andreasen, and P. H. Rasmussen, “Stable and high-yielding intrinsic 59Fe-radiolabeling of the intravenous iron preparations Monofer and Cosmofer,” Journal of Labelled Compounds and Radiopharmaceuticals, vol. 59, no. 9, pp. 375–382, 2016. View at Publisher · View at Google Scholar
  27. M. Lubberink, V. Tolmachev, S. Beshara, and H. Lundqvist, “Quantification aspects of patient studies with 52Fe in positron emission tomography,” Applied Radiation and Isotopes, vol. 51, no. 6, pp. 707–715, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Calonder, P. I. Würtenberger, R. P. Maguire, R. Pellikka, and K. L. Leenders, “Kinetic modeling of 52Fe/52 mMn-citrate at the blood-brain barrier by positron emission tomography,” Journal of Neurochemistry, vol. 73, no. 5, pp. 2047–2055, 1999. View at Google Scholar
  29. M. Bruehlmeier, K. L. Leenders, P. Vontobel, C. Calonder, A. Antonini, and A. Weindl, “Increased cerebral iron uptake in Wilson's disease: a 52Fe-citrate PET study,” Journal of Nuclear Medicine, vol. 41, no. 5, pp. 781–787, 2000. View at Google Scholar · View at Scopus
  30. F. Rösch, J. Brockmann, N. A. Lebedev, and S. M. Qaim, “Production and radiochemical separation of the Auger electron emitter 140Nd,” Acta Oncologica, vol. 39, no. 6, pp. 727–730, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Lubberink, H. Lundqvist, and V. Tolmachev, “Production, PET performance and dosimetric considerations of 134Ce/134La, an Auger electron and positron-emitting generator for radionuclide therapy,” Physics in Medicine and Biology, vol. 47, no. 4, pp. 615–629, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. M. M. Herth, V. L. Andersen, S. Lehel, J. Madsen, G. M. Knudsen, and J. L. Kristensen, “Development of a 11C-labeled tetrazine for rapid tetrazine-trans-cyclooctene ligation,” Chemical Communications, vol. 49, no. 36, pp. 3805–3807, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Gholipour, A. R. Jalilian, Y. Fazaeli et al., “Development of [62Zn/62Cu]-DOTA-rituximab as a possible novel in vivo PET generator for anti-CD20 antigen imaging,” Radiochimica Acta, vol. 102, no. 11, pp. 1035–1045, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Aghanejad, A. R. Jalilian, Y. Fazaeli, D. Beiki, B. Fateh, and A. Khalaj, “Radiosynthesis and biodistribution studies of [62Zn/62Cu]-plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging,” Journal of Radioanalytical and Nuclear Chemistry, vol. 299, no. 3, pp. 1635–1644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Ghandi, S. Feizi, F. Ziaie, Y. Fazaeli, and B. Notash, “Synthesis, characterization and in vivo evaluation of [62Zn]–benzo-δ-sultam complex as a possible pet imaging agent,” Annals of Nuclear Medicine, vol. 28, no. 9, pp. 880–890, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. M. R. Zalutsky, “Radionuclide therapy,” in Handbook of Nuclear Chemistry: Radiochemistry and Radiopharmaceutical Chemistry in Life Sciences, F. Rösch, A. Vertes, S. Nagy, and Z. Klencsar, Eds., Springer, Berlin, Germany, 4th edition, 2003. View at Google Scholar
  37. M. J. Adam and D. S. Wilbur, “Radiohalogens for imaging and therapy,” Chemical Society Reviews, vol. 34, no. 2, pp. 153–163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. P. E. Borchardt, R. R. Yuan, M. Miederer, M. R. McDevitt, and D. A. Scheinberg, “Targeted actinium-225 in Vivo generators for therapy of ovarian cancer,” Cancer Research, vol. 63, no. 16, pp. 5084–5090, 2003. View at Google Scholar · View at Scopus
  39. B. Bartoś, K. Lyczko, A. Kasperek, S. Krajewski, and A. Bilewicz, “Search of ligands suitable for 212Pb/212Bi in vivo generators,” Journal of Radioanalytical and Nuclear Chemistry, vol. 295, no. 1, pp. 205–209, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Elgqvist, S. Frost, J.-P. Pouget, and P. Albertsson, “The potential and hurdles of targeted alpha therapy—clinical trials and beyond,” Frontiers in Oncology, vol. 3, article 324, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Hamoudeh, M. A. Kamleh, R. Diab, and H. Fessi, “Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer,” Advanced Drug Delivery Reviews, vol. 60, no. 12, pp. 1329–1346, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. O. Sartor, B. N. Maalouf, C. R. Hauck, R. M. Macklis, C. Clinic, and L. College, “Targeted use of alpha particles: current status in cancer therapeutics,” Nuclear Medicine & Radiation Therapy, vol. 3, no. 4, pp. 1–8, 2012. View at Google Scholar
  43. R. M. de Kruijff, H. T. Wolterbeek, and A. G. Denkova, “A critical review of alpha radionuclide therapy-how to deal with recoiling daughters?” Pharmaceuticals, vol. 8, no. 2, pp. 321–336, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. F.-M. Su, P. Beaumier, D. Axworthy, R. Atcher, and A. Fritzberg, “Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator,” Nuclear Medicine and Biology, vol. 32, no. 7, pp. 741–747, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. V. Boudousq, L. Bobyk, M. Busson et al., “Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb,” PLoS ONE, vol. 8, no. 7, Article ID e69613, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. R. F. Meredith, J. Torgue, M. T. Azure et al., “Pharmacokinetics and imaging of 212Pb-TCMC-trastuzumab after intraperitoneal administration in ovarian cancer patients,” Cancer Biotherapy and Radiopharmaceuticals, vol. 29, no. 1, pp. 12–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Abbas, H. Heyerdahl, Ø. S. Bruland, J. Borrebæk, J. Nesland, and J. Dahle, “Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab,” EJNMMI Research, vol. 1, no. 1, pp. 1–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Mirzadeh, K. Kumar, and O. A. Gansow, “The chemical fate of 212Bi-DOTA formed by β decay of 212Pb(DOTA)2-∗∗∗,” Radiochimica Acta, vol. 60, no. 1, pp. 1–10, 1993. View at Publisher · View at Google Scholar
  49. M. Chérel, F. Davodeau, F. Kraeber-Bodéré, and J. F. Chatal, “Current status and perspectives in alpha radioimmunotherapy,” Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 50, no. 4, pp. 322–329, 2006. View at Google Scholar · View at Scopus
  50. P. P. Boldyrev, S. M. Deev, V. A. Golovachenko et al., “Determination of the labeling yield and stability of the complexes Bi-BSA-DOTA and Bi-BSA-DTPA,” Radiochemistry, vol. 56, no. 2, pp. 194–199, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Miederer, M. R. McDevitt, G. Sgouros, K. Kramer, N.-K. V. Cheung, and D. A. Scheinberg, “Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates,” Journal of Nuclear Medicine, vol. 45, no. 1, pp. 129–137, 2004. View at Google Scholar · View at Scopus
  52. S. Sofou, J. L. Thomas, H.-Y. Lin, M. R. McDevitt, D. A. Scheinberg, and G. Sgouros, “Engineered liposomes for potential α-particle therapy of metastatic cancer,” Journal of Nuclear Medicine, vol. 45, no. 2, pp. 253–260, 2004. View at Google Scholar · View at Scopus
  53. M. F. McLaughlin, J. Woodward, R. A. Boll et al., “Gold coated lanthanide phosphate nanoparticles for targeted alpha generator radiotherapy,” PLoS ONE, vol. 8, no. 1, Article ID e54531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Henriksen, K. Breistøl, Ø. S. Bruland, Ø. Fodstad, and R. H. Larsen, “Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model,” Cancer Research, vol. 62, no. 11, pp. 3120–3125, 2002. View at Google Scholar · View at Scopus
  55. H. Heyerdahl, N. Abbas, K. Sponheim, C. Mollatt, Ø. Bruland, and J. Dahle, “Targeted alpha therapy with 227Th-trastuzumab of intraperitoneal ovarian cancer in nude mice,” Current radiopharmaceuticals, vol. 6, no. 2, pp. 106–116, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. H. A. Wieder, M. Lassmann, M. S. Allen-Auerbach, J. Czernin, and K. Herrmann, “Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters,” World Journal of Radiology, vol. 6, no. 7, pp. 480–485, 2014. View at Publisher · View at Google Scholar
  57. S. V. Smith, N. Di Bartolo, S. Mirzadeh, R. M. Lambrecht, F. F. Knapp Jr., and E. L. Hetherington, “[166Dy]dysporium/[166Ho]holmium in vivo generator,” Applied Radiation and Isotopes, vol. 46, no. 8, pp. 759–764, 1995. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Pedraza-López, G. Ferro-Flores, C. Arteaga de Murphy et al., “Cytotoxic and genotoxic effect of the [166Dy]Dy/166Ho-EDTMP in vivo generator system in mice,” Nuclear Medicine and Biology, vol. 31, no. 8, pp. 1079–1085, 2004. View at Publisher · View at Google Scholar · View at Scopus